Merck KGaA (OTCMKTS:MKKGY) Short Interest Update

Merck KGaA (OTCMKTS:MKKGY - Get Free Report) was the target of a significant growth in short interest in March. As of March 31st, there was short interest totalling 61,400 shares, a growth of 6,722.2% from the March 15th total of 900 shares. Based on an average trading volume of 285,700 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.0% of the shares of the stock are short sold.

Merck KGaA Price Performance

Merck KGaA stock traded down $0.16 during midday trading on Friday, reaching $26.62. 69,065 shares of the company were exchanged, compared to its average volume of 138,414. Merck KGaA has a 1 year low of $24.32 and a 1 year high of $39.17. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.91 and a current ratio of 1.33. The firm's 50-day simple moving average is $27.90 and its 200-day simple moving average is $29.90. The company has a market capitalization of $17.20 billion, a price-to-earnings ratio of 16.43, a P/E/G ratio of 2.05 and a beta of 0.94.

Merck KGaA (OTCMKTS:MKKGY - Get Free Report) last issued its earnings results on Thursday, March 6th. The company reported $0.54 EPS for the quarter, beating the consensus estimate of $0.47 by $0.07. The company had revenue of $5.78 billion during the quarter, compared to analysts' expectations of $5.40 billion. Merck KGaA had a net margin of 12.89% and a return on equity of 10.41%. On average, analysts anticipate that Merck KGaA will post 1.87 EPS for the current year.

Merck KGaA Company Profile

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.